President's Message
News Release
February 22, 2021
|
[IPM(Innovative Pharma Model) Introduction Video] CMIC Group Released "Creative Service to Support Drug Development Journey in Japan" Video
January 22, 2021
|
Press Release
Announcement of Japan’s regulator approves Grifols’ Lynspad™ [alpha1-proteinase inhibitor] for the treatment of alpha-1 antitrypsin deficiency
January 22, 2021
|
Press Release
OrphanPacific, Inc. Receives Manufacturing and Marketing Approval of
ORLADEYO Capsules 150mg for Suppression of HAE Attacks in Japan
November 02, 2020
|
[Short Educational Video] CMIC Group Released C-CAST: Executive Interview, Philippe Auvaro
- Recent changes and current opportunities in Japan’s Pharmaceutical market
- CMIC’s IPM (Innovative Pharma Model)
August 21, 2020
|
[Short Educational Video] CMIC Group Released Two C-CASTs on;
- Expedited Review Programs in Japan
- In-Country Clinical Caretaker (ICCC) for Clinical Trials in Japan
We associate with the activities of Rare Disease Day JAPAN and support activities.
